Oncology is one of the fields experiencing a significant boost from artificial intelligence today; cancer detection, diagnosis, and treatment are all becoming much more efficient and accurate through the use of artificial intelligence. This review aims to demonstrate how AI is central to improving diagnostic early detection through imaging, biomarkers, and predictive analytics. It goes further on how predictive models based on AI make it easier to treat patients according to their risk and prognosis to determine appropriate management. The opportunities for personalized medicine in the application of artificial intelligence, such as in cancer treatment, radiation therapy, and drug development, are discussed. However, there are certain limitations to the integration of AI in oncology; some include data privacy issues, algorithmic bias and the issue of regulation, among others. Overcoming these limitations is essential to integrate AI into clinical practice effectively. As highlighted in this paper, profound ethical, technical, and integrationist processes must first be navigated to fully realize the potential of AI in transforming cancer systems. Drawing from HHI’s dual role of successful implementation featuring AI as a tool that closes gaps between innovation, implementation, and patients, there is a future where oncology is efficient, fair, and personalized.